Heska Corporation (HSKA) Position Increased by California Public Employees Retirement System
California Public Employees Retirement System raised its position in shares of Heska Corporation (NASDAQ:HSKA) by 38.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,880 shares of the medical research company’s stock after buying an additional 3,000 shares during the period. California Public Employees Retirement System’s holdings in Heska Corporation were worth $1,142,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in the stock. State Street Corp raised its position in shares of Heska Corporation by 47.3% in the fourth quarter. State Street Corp now owns 154,509 shares of the medical research company’s stock worth $11,063,000 after buying an additional 49,611 shares during the last quarter. Teachers Advisors LLC raised its position in shares of Heska Corporation by 4.0% in the fourth quarter. Teachers Advisors LLC now owns 9,493 shares of the medical research company’s stock worth $680,000 after buying an additional 364 shares during the last quarter. Louisiana State Employees Retirement System acquired a new position in shares of Heska Corporation during the first quarter worth about $262,000. Navellier & Associates Inc raised its position in shares of Heska Corporation by 173.2% in the first quarter. Navellier & Associates Inc now owns 8,430 shares of the medical research company’s stock worth $885,000 after buying an additional 5,344 shares during the last quarter. Finally, Acadian Asset Management LLC raised its position in shares of Heska Corporation by 54.2% in the first quarter. Acadian Asset Management LLC now owns 95,300 shares of the medical research company’s stock worth $10,005,000 after buying an additional 33,498 shares during the last quarter. 81.48% of the stock is currently owned by institutional investors.
Shares of Heska Corporation (HSKA) traded up 1.55% during midday trading on Friday, reaching $97.38. The company’s stock had a trading volume of 2,121 shares. The stock has a 50 day moving average price of $101.48 and a 200-day moving average price of $95.74. Heska Corporation has a 52-week low of $46.51 and a 52-week high of $115.00. The company has a market capitalization of $703.67 million, a price-to-earnings ratio of 49.63 and a beta of 0.82.
Heska Corporation (NASDAQ:HSKA) last posted its earnings results on Thursday, August 3rd. The medical research company reported $0.44 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.07. The business had revenue of $34.30 million during the quarter, compared to the consensus estimate of $33.35 million. Heska Corporation had a return on equity of 15.87% and a net margin of 10.70%. Heska Corporation’s revenue was up 14.3% on a year-over-year basis. During the same quarter last year, the company earned $0.35 EPS. Equities research analysts expect that Heska Corporation will post $2.04 EPS for the current year.
A number of equities analysts have issued reports on HSKA shares. B. Riley reaffirmed a “neutral” rating and issued a $83.00 target price on shares of Heska Corporation in a research report on Friday, April 28th. Zacks Investment Research lowered Heska Corporation from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 3rd. Aegis started coverage on Heska Corporation in a research report on Thursday, June 1st. They set a “buy” rating and a $114.50 price target on the stock. BidaskClub lowered Heska Corporation from a “buy” rating to a “hold” rating in a research report on Sunday, July 16th. Finally, Benchmark Co. upped their price target on Heska Corporation from $106.00 to $120.00 and gave the company a “buy” rating in a research report on Thursday, August 3rd. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $105.20.
In related news, EVP Nancy Wisnewski sold 250 shares of the firm’s stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $100.17, for a total transaction of $25,042.50. Following the completion of the transaction, the executive vice president now owns 38,901 shares in the company, valued at approximately $3,896,713.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Jason A. Napolitano sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $100.50, for a total value of $502,500.00. The disclosure for this sale can be found here. Insiders have sold a total of 30,265 shares of company stock valued at $2,983,439 in the last 90 days. 14.70% of the stock is owned by corporate insiders.
About Heska Corporation
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
Want to see what other hedge funds are holding HSKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heska Corporation (NASDAQ:HSKA).
Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.